Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT04545749
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04545749
Recruitment Status : Completed
First Posted : September 11, 2020
Last Update Posted : June 7, 2021
Vaxxinity, Inc.
Information provided by (Responsible Party):
United Biomedical Inc., Asia

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 18, 2021
Actual Study Completion Date : May 24, 2021